BRYTLY - Alcon Laboratories, Inc. | Global Packaging Systems

Manufacturer
Alcon Laboratories, Inc. | Global Packaging Systems
Effective date
2026-10-28
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
daily-update
Hydrated at
2026-10-31 01:02:48

Label at a glance#

ProductBRYTLY
Active ingredientApraclonidine Hydrochloride
Label structure12 sections

Dosage and administration

adults and children 12 years of age and over: instill 1 drop in the affected eye(s) every 12 hours do not use more than 2 times daily remove contact lenses before use  wait at least 10 minutes before re-inserting contact lenses after use  if using other ophthalmic products when using this product, wait at least 5 minutes between each product to avoid contamination, do not touch tip of container to any surface  rep...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Apraclonidine 0.125% (equivalent to apraclonidine hydrochloride 0.144%)

Purpose

OTC - PURPOSE SECTION

Redness reliever

Use

INDICATIONS & USAGE SECTION

Relieves redness of the eye due to minor eye irritations

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • if solution changes color or becomes cloudy 
  • if you are sensitive to any ingredient in this product

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience eye pain, changes in vision, continued redness or irritation of the eye 
  • condition persists for more than 3 days or worsens

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years of age and over:
    • instill 1 drop in the affected eye(s) every 12 hours
    • do not use more than 2 times daily
    • remove contact lenses before use 
    • wait at least 10 minutes before re-inserting contact lenses after use 
    • if using other ophthalmic products when using this product, wait at least 5 minutes between each product
    • to avoid contamination, do not touch tip of container to any surface 
    • replace cap after each use
  • children under 12 years of age: Do not use

Other information

OTHER SAFETY INFORMATION

  • store at 2°C to 25°C (36°F to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, citric acid (monohydrate), hypromellose 2910, purified water, sodium chloride, sodium citrate (dihydrate). Hydrochloric acid and sodium hydroxide may be used to adjust pH.

Questions or comments?

OTC - QUESTIONS SECTION

call 1-800-757-9195 or email alcon.medinfo@alcon.com

Primary Display Panel (5 mL)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BRYTLY®
APRACLONIDINE
OPHTHALMIC SOLUTION 0.125%

REDNESS RELIEVER EYE DROPS

LASTS UP TO 12 HOURS

works in 1 minute

STERILE  

5 mL (0.17 fl oz)  

Alcon  

Top Panel (Carton)

BRYTLY®
APRACLONIDINE
OPHTHALMIC SOLUTION 0.125%


CLINICALLY PROVEN
TO RELIEVE EYE REDNESS

Side Panel (Right of the PDP)

TAMPER EVIDENT: For your protection,
this bottle has an imprinted seal around
the neck. Do not use if seal is damaged
or missing at the time of purchase.  

BRYTLY®
APRACLONIDINE
OPHTHALMIC SOLUTION 0.125%
 

Push down while
turning to open cap

LASTS UP TO
12 HOURS


works in 1 minute

Country of Origin:
Switzerland

NDC: 0065-8596-04  

Fill Line  

MANUFACTURED BY:
Alcon Laboratories, Inc.
6201 South Freeway
Fort Worth, Texas 76134  

ACTUAL SIZE  

300073940-1125

Bottom Panel

LOT:                      EXP.:

Carton Label
Carton Label

Primary Display Panel (5 mL)

BRYTLY®
APRACLONIDINE
OPHTHALMIC SOLUTION 0.125%

REDNESS RELIEVER
EYE DROPS


STERILE  

5 mL (0.17 fl oz)  

Side Panel (Right of the PDP)

TAMPER EVIDENT: For your
protection, this bottle has an
imprinted seal around the neck.
Do not use if seal is damaged or
missing at the time of purchase. 

Alcon

____________________

LOT:                    EXP.:

300073974-1125

Side Panel (Left of the PDP)

Store at 2°C to 25°C (36°F to 77°F)

Manufactured by:
Alcon Laboratories, Inc.
Fort Worth, TX 76134

Bottle Label
Bottle Label

Primary Display Panel (0.5 mL)

PACKAGE NOT CHILD-RESISTANT

BRYTLY®
APRACLONIDINE
OPHTHALMIC SOLUTION 0.125%

REDNESS RELIEVER EYE DROPS

LASTS UP TO 12 HOURS

works in 1 minute

STERILE  

SAMPLE

0.5 mL (0.02 fl oz)  

Alcon

Top Panel (Carton)

BRYTLY®
APRACLONIDINE
OPHTHALMIC SOLUTION 0.125%

CLINICALLY PROVEN
TO RELIEVE EYE REDNESS


 Side Panel (Right of the PDP)

TAMPER EVIDENT: For your protection,
this bottle has an imprinted seal
around the neck. Do not use if seal is
damaged or missing at the time of use.  

BRYTLY®
APRACLONIDINE
OPHTHALMIC SOLUTION 0.125%
 

LASTS UP TO
12 HOURS


works in 1 minute

Country of Origin: Switzerland

NDC: 0065-8596-06

MANUFACTURED BY:
Alcon Laboratories, Inc.
6201 South Freeway
Fort Worth, Texas 76134

300073941-1125

Bottom Panel

LOT:                      EXP.:

Sample Carton
Sample Carton

Primary Display Panel (0.5 mL)

PACKAGE NOT CHILD-RESISTANT

BRYTLY®
APRACLONIDINE
OPHTHALMIC SOLUTION 0.125%

REDNESS RELIEVER
EYE DROPS


STERILE

0.5mL (0.02 fl oz)

Alcon

Side Panel (Right of the PDP)


SAMPLE

Store at 2°C to 25°C (36°F to 77°F). Manufactured by:
Alcon Laboratories, Inc., Fort Worth, TX 76134 USA.
TAMPER EVIDENT: For your protection, this bottle has
an imprinted seal around the neck. Do not use if seal
is damaged or missing at the time of use.

_____________________

LOT:                      EXP.:

300073975-1125

Sample Bottle
Sample Bottle

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0065-85960065-8596-04, 0065-8596-05, 0065-8596-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N220341-001BRYTLYAPRACLONIDINE HYDROCHLORIDEEQ 0.125% BASESOLUTION/DROPS / OPHTHALMICRLD, RS2026-10-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N220341-001BRYTLYEQ 0.125% BASESOLUTION/DROPS / OPHTHALMICRLD, RS2026-10-16d4dbc9d85df4…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BRYTLYAPRACLONIDINE HYDROCHLORIDEAlcon Laboratories, Inc.a64eaf7f-448e-4def-bddc-f6919d06b3572026-10-28WarningsExact identifier
ndc (package): 0065-8596-06
ndc (package): 0065-8596-05
ndc (package): 0065-8596-04
ndc (product): 0065-8596
ndc11 (package): 00065859606
ndc11 (package): 00065859605
ndc11 (package): 00065859604
spl id: 11291732-f127-4857-9b74-4409975ac779
spl set id: a64eaf7f-448e-4def-bddc-f6919d06b357

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.